FDA Inspection
Sri Krishna Pharmaceuticals, Ltd. - Unit IIISri Krishna Pharmaceuticals, Ltd. - Unit III – FDA Inspection, Jul 31, 2023
Record Details
This FDA Inspection record concerns Sri Krishna Pharmaceuticals, Ltd. - Unit III, with an inspection on July 31, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bfd65ca0-6288-4752-be58-bf323fa42b5c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1216334
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sri Krishna Pharmaceuticals, Ltd. - Unit III
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 25, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sri Krishna Pharmaceuticals, Ltd. - Unit III
- FDA Inspection 954833 - 2015-10-23
- FDA Inspection 757343 - 2011-11-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.